Peptides
Longevity peptides graded on human trials, safety and sourcing — from approved drugs to the compounded catalogue.
Topic overview →Peptides and therapies commonly used to extend lifespan.
Being commonly used in longevity clinics is a poor proxy for evidence, and this ranking separates the two. GLP-1 receptor agonist peptides (semaglutide, tirzepatide and related drugs) rank first, because randomised outcome trials show reduced cardiovascular events and death in people with obesity or type 2 diabetes, giving this category the strongest human evidence of any peptide commonly discussed in longevity circles, even though it is prescribed for weight and metabolic disease rather than marketed as anti-ageing. Growth-hormone-releasing peptides (sermorelin, ipamorelin, CJC-1295 and similar) rank second from the bottom of a much shorter positive list, because while they reliably raise growth hormone and IGF-1 levels, human trials link elevated IGF-1 in adulthood to increased, not decreased, certain cancer risks, and no trial shows these peptides extend human lifespan. BPC-157 and similar repair-marketed peptides rank near the bottom, commonly used for injury recovery claims with essentially no human trials — most evidence is from animal studies, and it remains unapproved for human use in most jurisdictions. NAD+ infusion therapy ranks similarly low, popular in longevity clinics with no randomised trials demonstrating a lifespan or major health outcome benefit in humans, only mechanistic and animal data. 'Longevity peptide stacks' combining several unapproved peptides rank lowest, compounding the lack of evidence for each individual component with unknown interaction effects and inconsistent sourcing quality, since most are not manufactured under pharmaceutical-grade regulatory oversight.
PharmD-reviewed · Updated
Which longevity peptides are best for energy and recovery?
No peptide sold for energy or recovery has been shown to improve either in a controlled human trial of healthy adults. Ranked on the human evidence that does exist, the order is: tesamorelin (approved, but for HIV-related abdominal fat — not energy), sermorelin (once approved, reliable growth-hormone pharmacology, one small ageing trial), then a long tail — DSIP, semax, selank — with old and contradictory trial records, and finally BPC-157, TB-500, MOTS-c, CJC-1295 and ipamorelin, whose recovery and energy claims rest entirely on animal work. The honest answer to 'which is best' is that the best-evidenced options for recovery are not peptides at all.
PharmD-reviewed · Updated
What are the safest and best longevity peptides?
Ranked on safety and evidence together — because in peptides the two are the same question: a peptide's safety profile is only known where it has been through human trials — the safest and best longevity peptides are the approved ones used within their indication: tesamorelin (approved, Phase 3 safety data, for HIV-associated abdominal fat), and PT-141 / bremelanotide (approved, for a specific indication in premenopausal women), followed by sermorelin (an approved diagnostic with a long safety record and thin ageing evidence). Below them sit GHK-Cu (topical, a genuine safety record in skincare, no systemic longevity data), semax and selank (decades of prescription use in Russia, no Western safety review), and DSIP (old small trials). At the bottom — not because they are known to be dangerous but because nobody knows — are the injectables sold online with no completed human trial and no lawful compounding route in most jurisdictions: BPC-157, TB-500, MOTS-c, CJC-1295 and ipamorelin, epitalon, AOD-9604, and melanotan II, which does have documented harms. No peptide has evidence of extending human lifespan. Any peptide should be screened against existing medication by a pharmacist.
PharmD-reviewed · Updated
Best longevity peptides for anti-aging and cellular repair.
Ranked on human evidence for the specific repair or anti-ageing claim each peptide carries, the list is short at the top: GHK-Cu applied to skin has small human trials showing improved skin appearance and wound healing, and ranks first because it is the only peptide with a measured repair effect in people; tesamorelin has Phase 3 evidence for reducing visceral fat and a signal on liver fat, which is a metabolic-ageing effect if not a repair one; thymosin alpha-1 has immune-modulation trials in specific diseases. Everything else sold for cellular repair — BPC-157 (tissue healing), TB-500 (tissue repair), epitalon (telomeres), MOTS-c (mitochondria), sermorelin and CJC-1295/ipamorelin (growth hormone), SS-31 (mitochondrial membranes, a real drug candidate in trials) — has animal or cell data, an early trial for a disease that is not ageing, or nothing. No peptide has been shown to repair cells or slow ageing in a healthy human. The compounds with the strongest human evidence for cellular-repair biology are not peptides.
PharmD-reviewed · Updated
Which longevity peptides work best for lifespan extension?
No peptide has been shown to extend human lifespan, and none has a trial designed to test it. Ranked on how close the evidence comes: SS-31 (elamipretide) and MOTS-c have the best mechanistic case — mitochondrial peptides with rodent data on function and, for MOTS-c, healthspan markers — and no human ageing trial; humanin has a striking association with longevity in centenarian cohorts and no intervention trial; epitalon has decades-old Russian reports of extended lifespan in animals and in small elderly cohorts, never independently replicated; tesamorelin and the growth-hormone secretagogues rank low because the axis they raise is, in most ageing biology, associated with shorter life when higher, not longer; BPC-157, TB-500 and the rest have no lifespan data of any kind. The interventions with the strongest human evidence bearing on lifespan — blood-pressure and lipid control, not smoking, exercise — are not peptides, and the compounds with the best animal lifespan data in independent programmes are small molecules such as rapamycin, not peptides.
PharmD-reviewed · Updated
Best longevity peptides for beginners to start with.
The best peptide for a beginner is the one that is lawful to obtain, prescribed and monitored by a clinician, studied in humans, and low-risk by route — and ranked on those four tests the list runs: topical GHK-Cu first (over the counter, human skin trials, no injection, no systemic exposure); then an approved peptide through a prescriber if there is a genuine indication — tesamorelin for its approved use, PT-141 for its approved use, sermorelin where a clinician judges it appropriate — with baseline and follow-up blood tests; then nothing. The injectables beginners are usually sold first — BPC-157, TB-500, a CJC-1295/ipamorelin blend — rank last for a beginner specifically: no human trial, no lawful compounding route in most jurisdictions, unverified purity, an injection to learn, and no one monitoring the result. The honest beginner's stack is a skin cream, a blood panel and a conversation with a pharmacist; the honest beginner's longevity intervention is not a peptide.
PharmD-reviewed · Updated
What are the top doctor-recommended longevity peptides?
'Doctor-recommended' covers three different things, and the peptides rank by which one applies: recommended within guidelines for an approved indication — tesamorelin for HIV-associated abdominal fat and bremelanotide (PT-141) for a specific sexual-desire disorder — is the strongest; recommended off-label by a clinician who runs baseline and follow-up tests, on a known pharmacology with thin ageing evidence — sermorelin, and tesamorelin used outside its indication — is the middle; and recommended on a longevity-clinic menu, where the recommending clinician also sells the product and the peptide has no human trial and no lawful compounding route — BPC-157, TB-500, CJC-1295/ipamorelin, MOTS-c, epitalon — is the weakest, and the most common. Thymosin alpha-1 and SS-31 have physician-led trials for specific diseases and are not lawfully available for ageing. No peptide is recommended by any medical guideline for longevity, because none has the evidence a guideline would require.
PharmD-reviewed · Updated
Best longevity peptides for skin health and wrinkle reduction.
Ranked on human evidence for skin appearance and wrinkle reduction, the best peptides are all topical: GHK-Cu (copper peptide) first, with small controlled trials on elasticity, fine lines and wound healing; palmitoyl pentapeptide-4 (Matrixyl) second, with a handful of small vehicle-controlled trials on wrinkle depth; palmitoyl tripeptide and tetrapeptide combinations third, mostly manufacturer studies; acetyl hexapeptide-8 (Argireline) fourth, with modest trial effects on expression lines that are far smaller than the 'topical botox' claim; and oral collagen peptides fifth, with meta-analyses showing small improvements in hydration and elasticity from industry-funded trials. Every one of them ranks below retinoids and daily sunscreen, which have larger and longer randomised trials for photoageing than all skin peptides combined. Injectable GHK-Cu and epitalon sold for 'skin rejuvenation' have no human skin trial by that route and rank last. Peptides are a reasonable third line in a skincare routine; they are not the first.
PharmD-reviewed · Updated
Best clinically studied longevity peptides for healthy aging.
Ranked strictly on completed human trials — how many, how large, how long, and what they measured — the clinically studied longevity peptides are: tesamorelin (multiple Phase 3 trials, hundreds of participants, visceral fat in HIV lipodystrophy; a later trial on liver fat); bremelanotide/PT-141 (Phase 3, sexual desire disorder); SS-31/elamipretide (Phase 2 and 3 in Barth syndrome and mitochondrial myopathy, mixed results); thymosin alpha-1 (trials in hepatitis, sepsis and oncology); GHK-Cu (small vehicle-controlled skin trials); sermorelin (older trials in growth-hormone deficiency and a few small ageing studies); DSIP (1980s sleep trials that disagree); AOD-9604 (a Phase 2b obesity trial that failed). Below that line — BPC-157, TB-500, MOTS-c, CJC-1295, ipamorelin, epitalon — there is no completed human trial for the use they are sold for. And above the whole list sits the fact that none of the trials was in healthy ageing adults with an ageing outcome: 'clinically studied' is true for the top eight, and 'for healthy ageing' is true for none.
PharmD-reviewed · Updated
How to choose the best longevity peptides safely?
Choose a longevity peptide safely by asking seven questions in order, ranked here by how much of the market each one eliminates: What specific problem is it for — 'longevity' is not an indication, and this question removes most purchases; Is there a lawful, quality-controlled route to obtain it — prescription, pharmacy or cosmetic product — which removes every research-chemical injectable; Has it been studied in humans for that problem — which leaves tesamorelin, PT-141, sermorelin, GHK-Cu and little else; Is the route of administration the lowest-risk one that answers the question — topical before nasal before injectable; Who supplies it and can the purity, sterility and dose be verified; Who monitors the result — a baseline and follow-up panel with a clinician; and Has a pharmacist screened it against existing medication. A peptide that survives all seven is almost always an approved product prescribed for its indication, or a copper-peptide cream. The method is safe precisely because it ends there for most people.
PharmD-reviewed · Updated
Best longevity peptides stack for maximum longevity benefits.
Ranked on evidence, interaction risk and lawful sourcing, the best longevity peptide stack for maximum benefit contains at most one peptide — and it is not the stacks sold under that name. The evidence-based 'stack' is a copper-peptide cream for skin, plus an approved peptide only where a genuine indication and a prescriber exist, plus the non-peptide interventions that carry all the longevity evidence: resistance training, blood-pressure and ApoB control, not smoking, sleep, and a screened supplement list. Against that, the stacks marketed online rank as follows: the 'healing stack' (BPC-157 + TB-500) combines two peptides with no human trial and no lawful route; the 'anti-ageing GH stack' (CJC-1295 + ipamorelin, sometimes with sermorelin or tesamorelin) compounds growth-hormone secretagogues with additive effects on IGF-1 and glucose and regulatory citations; the 'mitochondrial stack' (MOTS-c + SS-31 + NAD) stacks an untested peptide with a drug candidate not available for this use; the 'cognitive stack' (semax + selank + DSIP) combines unreviewed nasal peptides with sedative interactions; and the 'full longevity stack' that combines all of them multiplies every unknown. Stacking peptides adds interaction risk faster than it adds evidence, because the evidence for any single one is already near zero.
PharmD-reviewed · Updated
Peptide therapy at longevity clinics: what is actually prescribed
Peptide therapy at longevity clinics spans two very different categories that are usually presented as one. Some peptides are FDA-approved medicines with substantial trial evidence. Others have no completed human efficacy trial and no approved formulation, and are supplied as compounded or research-grade material. Medical supervision changes the sourcing and monitoring — it does not create evidence that has not been generated.
PharmD-reviewed · Updated
The Longevity Brief
One evidence-graded email a week: what is new in longevity research, what is hype, and the one change actually worth making.
Free · one email a week · unsubscribe anytime.